Company Filing History:
Years Active: 2002-2004
Title: Rachel A Meyers: Innovator in Protein Kinase Research
Introduction
Rachel A Meyers is a prominent inventor based in Newton, MA (US). She has made significant contributions to the field of molecular biology, particularly in the area of protein kinases. With a total of 7 patents to her name, her work has advanced our understanding of novel protein families and their applications.
Latest Patents
Among her latest patents are 2504, 15977, and 14760, which focus on novel protein kinase family members and their uses. These inventions provide isolated nucleic acid molecules that encode these novel proteins. Additionally, they include antisense nucleic acid molecules, recombinant expression vectors, and nonhuman transgenic animals that have had these genes introduced or disrupted. Furthermore, her patents encompass isolated proteins, fusion proteins, antigenic peptides, and antibodies related to these novel kinases. Another significant patent is 26934, which describes a novel cytidine deaminase-like molecule and its various applications. This invention includes isolated proteins, fusion proteins, and nucleic acid molecules, along with diagnostic and therapeutic methods utilizing these compositions.
Career Highlights
Rachel A Meyers is currently associated with Millennium Pharmaceuticals Limited, where she continues her innovative research. Her work has not only contributed to scientific knowledge but has also paved the way for potential therapeutic applications.
Collaborations
Some of her notable coworkers include Laura A Rudolph-Owen and Rosana Kapeller-Libermann, who have collaborated with her on various projects.
Conclusion
Rachel A Meyers stands out as a leading inventor in the field of protein kinase research, with a strong portfolio of patents that highlight her innovative contributions. Her work continues to influence the scientific community and holds promise for future advancements in biotechnology.